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Pericytes play a key role in the development of cere-
bral microcirculation. The exact role of pericytes in
the neurovascular unit in the adult brain and during
brain aging remains, however, elusive. Using adult
viable pericyte-deficient mice, we show that pericyte
loss leads to brain vascular damage by two parallel
pathways: (1) reduction in brain microcirculation
causing diminished brain capillary perfusion, cere-
bral blood flow, and cerebral blood flow responses
to brain activation that ultimately mediates chronic
perfusion stress and hypoxia, and (2) blood-brain
barrier breakdown associated with brain accumula-
tion of serum proteins and several vasculotoxic
and/or neurotoxic macromolecules ultimately lead-
ing to secondary neuronal degenerative changes.
We show that age-dependent vascular damage in
pericyte-deficient mice precedes neuronal degener-
ative changes, learning andmemory impairment, and
the neuroinflammatory response. Thus, pericytes
control key neurovascular functions that are neces-
sary for proper neuronal structure and function, and
pericyte loss results in a progressive age-dependent
vascular-mediated neurodegeneration.
INTRODUCTION
An intact functional neurovascular unit is comprised of endothe-
lial cells, pericytes, glia, and neurons (Zlokovic, 2008; Lo and
Rosenberg, 2009; Segura et al., 2009; Iadecola, 2010). Pericytes
ensheath the capillary wall, making direct contacts with endo-
thelial cells (Armulik et al., 2005; Dı´az-Flores et al., 2009). Endo-
thelial-secreted platelet-derived growth factor B (PDGF-B) binds
to the platelet-derived growth factor receptor beta (PDGFRb) on
pericytes, initiating multiple signal transduction pathways regu-
lating proliferation, migration, and recruitment of pericytes to
the vascular wall (Armulik et al., 2005; Lebrin et al., 2010).
Much of the insight into brain pericyte biology arose from devel-opmental studies and the analysis of pericyte-deficient trans-
genic mice with disrupted PDGF-B/PDGFRb signaling (Lindahl
et al., 1997; Lindblom et al., 2003; Tallquist et al., 2003; Gaengel
et al., 2009).
In the developing central nervous system (CNS), pericyte loss
in embryonic lethal PDGF-B null and PDGFRb null mice leads to
endothelial cell hyperplasia, suggesting that pericytes control
endothelial cell number and microvessel architecture but do
not determine microvessel density, length, or branching (Lindahl
et al., 1997; Hellstro¨m et al., 1999, 2001). Earlier in vitro studies
have also demonstrated that pericytes inhibit endothelial cell
proliferation (Orlidge and D’Amore, 1987; Hirschi et al., 1999).
Endothelial-specific PDGF-B deletion results in viable mice that
develop diabetic-like proliferative retinopathy, characterized by
an increased number of acellular regressing capillaries (Enge
et al., 2002). In experimental models of diabetic retinopathy,
hyperglycemia has been found to lead to diminished PDGFRb
signaling resulting in pericyte apoptosis (Geraldes et al., 2009),
increased endothelial cell proliferation, and increased numbers
of acellular capillaries in pericyte-deficient Pdgfb+/ mice
(Hammes et al., 2002). In contrast, studies focusing on tumor
angiogenesis have suggested that pericyte loss may indeed
lead to endothelial apoptosis (Song et al., 2005). Therefore, it
is unclear as to what role pericytes may play in modulating
the adult cerebrovascular microcirculatory structure and/or
function.
In the adult brain, pericytes modulate capillary diameter by
constricting the vascular wall (Peppiatt et al., 2006), a process
which during ischemia may obstruct capillary blood flow
(Yemisci et al., 2009; Vates et al., 2010). Still, relatively little is
known about the role of pericytes in vascular maintenance in
the adult and aging brain. It is also unknown whether pericyte
degeneration can influence the neuronal phenotype. Using two
different adult viable pericyte-deficient mouse strains with vari-
able degrees of pericyte loss (Tallquist et al., 2003; Winkler
et al., 2010), we have investigated whether pericyte loss in
the adult brain and during aging can influence brain capillary
density, resting cerebral blood flow (CBF), CBF response to
brain activation, and blood-brain barrier (BBB) integrity to
serum proteins and blood-derived potentially cytotoxic and/or
neurotoxic molecules. We have also studied the effects of
an age-dependent pericyte loss and resulting hemodynamicNeuron 68, 409–427, November 4, 2010 ª2010 Elsevier Inc. 409
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Figure 1. Age-Dependent Pericyte Loss and Brain Microvascular Regression in Mice with Pericyte-Specific PDGFRb Deficient Signaling
(A) Confocal microscopy analysis of PDGFRb on perivascular pericytes (red), SMI-32 neurofilament marker (green, top), neuronal-specific marker NeuN (green,
bottom) and lectin-positive brain capillaries (blue) in the layer II parietal cortex of 2-month-old Pdgfrb+/+ and Pdgfrb+/mice showing no colocalization of PDGFRb
with neurons.
(B) Representative confocal microscopy analysis of desmin immunodetection showing pericyte coverage (red) of lectin-positive brain capillaries (green) in the
parietal cortex of an 8-month-old Pdgfrb+/+ mouse and 1-, 8-, and 16-month-old Pdgfrb+/ mice.
(C) Age-dependent loss of pericyte coverage in the cortex and hippocampus of 1-, 6- to 8-, and 14- to 16-month-old Pdgfrb+/ mice (black bars) and in 6- to
8-month-old F7 mice (gray bars) compared to age-matched Pdgfrb+/+ controls (white bars). Pericyte coverage was determined as a percentage (%) of des-
min-positive pericyte surface area covering lectin-positive capillary surface area that was arbitrarily taken as 100%. Total of 36 and 24 randomly chosen fields
(4203 420 mm) from six nonadjacent cortical and hippocampal sections, respectively, were analyzed per mouse. Mean ± SEM, n = 6mice per group; *p < 0.05 or
**p < 0.01 by one-way ANOVA.
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neuroinflammation.
RESULTS
Reductions in Cerebral Microcirculation and Blood Flow
in Pericyte-Deficient Mice
We have recently reported that PDGFRb is exclusively ex-
pressed in pericytes, and not in neurons, astrocytes, or endothe-
lial cells, in different brain regions of adult viable 129S1/SvlmJ
mice with normal or deficient PDGFRb signaling (Winkler et al.,
2010). Therefore, a genetic disruption of PDGFRb signaling in
Pdgfrb+/mice and the F7 homozygous mutants with two hypo-
morphic alleles of Pdgfrb exhibiting 35% and 65% pericyte
loss in the embryonic CNS, respectively (Tallquist et al., 2003),
results in a primary pericyte-specific insult.
Using three-color confocal imaging analysis for PDGFRb
and the well-established pericyte markers chondroitin sulfate
proteoglycan NG2 (Armulik et al., 2005; Peppiatt et al., 2006;
Pfister et al., 2008; Yemisci et al., 2009) and desmin (Hellstro¨m
et al., 1999;Tallquist et al., 2003; Song et al., 2005; Kokovay
et al., 2006), along with endothelial-specific Lycopersicon escu-
lentum lectin fluorescent staining to visualize brain capillary
profiles, we show that PDGFRb colocalizes with pericytes on
brain capillaries, as illustrated in cortical layer II and hippocampal
CA1 regions in 6-month-old Pdgfrb +/+ control mice (Figures
S1A–S1C, available online), as reported (Winkler et al., 2010).
There was no detectable colocalization of PDGFRbwith the neu-
rofilament-H marker of neuronal cell processes (SMI-32) or the
neuronal-specific nuclear antigen A60 (NeuN), as illustrated in
cortical layers II and III in 2-month-old Pdgfrb+/+ and Pdgfrb+/
mice, respectively (Figure 1A), which corroborates a previous
report showing that PDGRFb is not expressed in neurons in
viable F7 mutants (Winkler et al., 2010). Hematoxylin and eosin
staining provides a low-magnification view of a control mouse
cerebral hemisphere adjacent to sections subsequently utilized
for all fluorescent imaging experiments (Figure S1A).
Using dual immunostaining for desmin- and lectin-positive
brain capillary profiles, we show an age-dependent progressive
loss of pericyte coverage in the cortex (Figures 1B–1C) and
hippocampus (Figure 1C) and other brain regions (data not
shown) in adult viable Pdgfrb+/ mice compared to Pdgfrb+/+
age-matched littermate controls, i.e., approximately 20%,
40%, and 60% loss at 1, 6–8, and 14–16 months of age, respec-
tively. An age-dependent pericyte loss in Pdgfrb+/ mice has
been confirmed by counting NG2-positive pericytes per mm2
of endothelial-specific CD31-positive capillary profiles (Figures
S1D–S1E). Pdgfrb+/+ control mice did not show significant differ-
ences in pericyte coverage between 1, 6–8, and 14–16 months
of age (Figure 1C).(D) Length of lectin-positive capillary profiles in the cortex and hippocampus of 1
mice (black bars), and 6- to 8-month-old F7 mice (gray bars). Total of 36 and 24 o
analyzed per mouse, respectively. Mean ± SEM, n = 6 mice per group; *p < 0.05
(E) Positive correlation between age-dependent reduction in capillary length and lo
from 1- (red), 6- to 8- (blue), and 14- to 16-month-old (black) Pdgfrb+/ mice (n =
(F) Confocal microscopy analysis of TUNEL (green, top), PDGFRb immunodete
6-month-old Pdgfrb+/+, 1- and 6-month-old Pdgfrb+/, and 6-month-old F7 mice
detaching pericyte; Open arrow indicates TUNEL-positive endothelial cell (see FIn contrast to endothelial hyperplasia in Pdgfrb/ embryonic
CNS (Hellstro¨m et al., 2001) and lack of vascular changes during
CNS development in Pdgfb+/ and Pdgfrb+/ embryos (Leve´en
et al., 1994; Soriano, 1994), we show that amodest pericyte defi-
ciency in 1-month-old Pdgfrb+/ mice results in a significant
(20%–25%) postnatal reduction in the microvascular length in
the cortex and hippocampus and other brain regions (data not
shown), as demonstrated by lectin-positive (Figures 1B and
1D) and CD31-positive (Figures S1D and S1F) capillary profiles.
We also show an age-dependent progressive reduction in
Pdgfrb+/ mice of lectin-positive and/or CD31-positive micro-
vascular profiles in the cortex and hippocampus by 30%–34%
and 50%–52% at 6–8 and 14–16 months, respectively (Figures
1B and 1D and Figures S1D and S1F).
There was a strong positive correlation between an age-
dependent loss in both pericyte coverage and pericyte number
and microvascular reductions (Figure 1E and Figure S1G), indi-
cating that pericyte degeneration is associated with progressive
age-dependent microvascular degeneration. This was corrobo-
rated in 6- to 8-month-old F7 mutant mice and Pdgfrb+/ mice
by showing that F7 mutants, which exhibit a significantly greater,
i.e., 60%, pericyte loss in the cortex and hippocampus than
Pdgfrb+/ mice (Figure 1C), had significantly greater 45%–53%
loss in the microvascular length in the cortex and hippocampus
compared to 30%–34% reduction in Pdgfrb+/mice (Figure 1D).
Using three-color immunostaining for pericytes and endothelial
cells and terminal deoxynucleotidyl transferase dUTP nick end
labeling (TUNEL) staining for DNA fragmentation suggestive of
apoptotic and/or necrotic cell death, we show that Pdgfrb+/
and F7 mice, but not the control Pdgfrb+/+ mice, occasionally
display degenerating pericytes associated with degenerating
TUNEL-positive capillary endothelium, as illustrated in the cortex
of 1- and 6-month-old Pdgfrb+/ and 6-month-old F7 mice
(Figure 1F).
Using in vivo multiphoton microscopy imaging of fluorescein-
conjugated mega-dextran (MW = 2,000,000 Da), we generated
3D 0.5 mm Z stack cortical angiograms in Pdgfrb+/ mice and
age-matched controls to find out whether microvascular reduc-
tions determined by histological quantification (Figure 1D and
Figure S1F) reflect a capillary perfusion deficit in vivo. The anal-
ysis of angiograms has indicated an age-dependent reduction in
the length of perfused cortical microvessels, i.e., by 18%, 30%,
and 47% at 1, 6–8, and 14–16 months of age, respectively
(Figures 2A–2B). These results were comparable to the reduc-
tions determined by histological analysis, indicating no discrep-
ancy between the two methods. There was a strong positive
correlation between age-dependent reductions in pericyte loss
and perfused capillary length (Figure 2C). The F7 mutant mice
at 6–8 months of age exhibited significantly greater reduction
in the perfused cortical vascular length compared to 6- to-, 6- to 8-, and 14- to 16-month-old Pdgfrb+/+ mice (white bars) and Pdgfrb+/
bservations in the cortex and hippocampus from the same fields as in C were
or **p < 0.01 by one-way ANOVA.
ss of pericyte coverage in the cortex of Pdgfrb+/mice. Single data points were
18). r = Pearson’s coefficient.
ction on pericytes (red) and lectin-positive capillaries (blue) in the cortex of
. Closed arrow indicates TUNEL-positive attached pericyte; *, TUNEL-positive
igure S1).
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Figure 2. Diminished Brain Capillary Perfusion and Changes in CBF in Pericyte-Deficient Mice
(A) Perfusion of cortical microvessels studied by in vivo multiphoton microscopy analysis of fluorescein-conjugated mega-dextran (MW = 2,000,000; green) in an
8-month-old Pdgfrb+/+ mouse, and 1-, 8-, and 16-month-old Pdgfrb+/ mice.
(B) Quantification of perfused capillary length from angiograms obtained as in (A). in 1-, 6- to 8-, and 14- to 16-month-oldPdgfrb+/+mice (white bars) andPdgfrb+/
mice (black bars), and in 6- to 8-month-old F7 mice (gray bars). Two to three angiograms were analyzed per mouse.
(C) Positive correlation between age-dependent reductions of brain capillary perfusion and desmin-positive pericyte coverage of cortical capillaries in Pdgfrb+/
mice. Single data points were from 1- (red), 6- to 8- (blue), and 14- to 16-month-old (black) Pdgfrb+/ mice (n = 18). r = Pearson’s coefficient.
(D) IAP autoradiography of the CBF in an 8-month-old Pdgfrb+/+ mouse, 1- and 8-month-old Pdgfrb+/ mice and an 8-month-old F7 mouse.
(E) Local CBF determined with 14C-IAP autoradiography as in (D). in 1-, 6- to 8-, and 14- to 16-month-old Pdgfrb+/+ mice (white bars) and Pdgfrb+/mice (black
bars), and in 6- to 8-month-old F7 mice (gray bars). See Table S1.
(F) CBF responses to whisker-barrel cortex vibrissal stimulus (% increase from basal values) in 1-, 6- to 8-, and 14- to 16-month-old Pdgfrb+/+ mice (white bars)
and Pdgfrb+/ mice (black bars).
(G) Positive correlation between diminished CBF responses to a stimulus and an age-dependent loss of pericyte coverage of cortical capillaries inPdgfrb+/mice.
Single data points were from 1- (red), 6- to 8- (blue), and 14- to 16-month-old (black) Pdgfrb+/ mice (n = 18). r = Pearson’s coefficient.
In (B, C, E, and F) mean ± SEM, n = 6 mice per group; *p < 0.05 or **p < 0.01 by one-way ANOVA.
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30% of controls, respectively (Figure 2B), consistent with signif-
icantly greater pericyte degeneration. In these studies, imaging
of perfused capillaries was accomplished within 40 min of the
cranial window surgery before any significant inflammation or
gliosis is present (see Supplemental Experimental Procedures).
Given that regional brain capillary density correlates with
blood flow (Zlokovic, 2008), we hypothesized that pericyte-defi-
cient mice will have diminished resting CBF. 14C-iodoantipyrine
quantitative autoradiography revealed significant (23%–24%,
33%–37%, and 48%–50%) age-dependent reductions in the
local CBF in the cortex and hippocampus of 1-, 6- to 8-, and
14- to 16-month-old Pdgfrb+/ mice compared to age-matched
controls, respectively (Figures 2D–E). The F7 mutants at
6–8 months of age had greater CBF reductions in the cortex
and hippocamus than 6- to 8-month-old Pdgfrb+/ mice, i.e.,
49% and 41%, respectively (Figure 2E). Significant CBF reduc-
tions were found in other studied brain regions of pericyte-defi-
cient mice (Table S1).
Laser Doppler flowmetry showed diminished CBF responses
to whisker-barrel cortex vibrissal stimulation in 1-, 6- to 8-, and
14- to 16-month-old Pdgfrb+/ mice to 27%, 21%, and 12% of
basal values, respectively, compared to 32%, 34%, and 31%
in the corresponding age-matched controls, respectively
(Figure 2F). There was a significant positive correlation between
the loss of pericyte coverage and diminished CBF responses
during aging of Pdgfrb+/mice (Figure 2G). The observed dysre-
gulated CBF response in pericyte-deficient mice is consistent
with previous findings, suggesting that pericytes participate in
the control of brain capillary diameter in response to a stimulus
(Peppiatt et al., 2006).
BBB Breakdown in Pericyte-Deficient Mice
Early electron microscopy studies have shown that pericytes
prevent entry of circulating exogenous horseradish peroxidase
into the brain, suggesting pericytes are part of the BBB for
macromolecules (reviewed in Dı´az-Flores et al., 2009). Whether
degenerating pericytes in the aging brain can maintain the
BBB in vivo against endogenous circulating macromolecules,
some of which are potentially cytotoxic and/or neurotoxic is,
however, unknown. To test this hypothesis, we studied whether
plasma-derived proteins accumulate in the brains of pericyte-
deficient mice. Immunostaining for plasma-derived immuno-
globulin G (IgG) and endothelial lectin, performed as we
described (Zhong et al., 2008), revealed significant perivascular
IgG deposits and >3-fold increase in IgG accumulation in the
hippocampus and cortex in 1-month-old Pdgfrb+/ mice com-
pared to controls (Figures 3A and 3B and Figure S2A). There
was a progressive BBB breakdown to IgG resulting in approxi-
mately 8- to 10-fold, and 20- to 25-fold greater IgG perivascular
accumulation in the hippocampus and cortex of 6- to 8- and
14- to 16-month-old Pdgfrb+/ mice compared to age-matched
controls, respectively, and a 16- to 18-fold increase in the hippo-
campus and cortex in 6- to 8-month-old F7 mutants (Figure 3C
and Figure S2B). We also show a significant negative correla-
tion between the perivascular IgG brain accumulation and
pericyte coverage in Pdgfrb+/mice (Figure 3D and Figure S2C).
In contrast, there was no detectable IgG leakage in controlmice. High-resolution confocal microscopy confirmed the IgG
perivascular accumulation around capillaries lacking pericyte
coverage and in brain endothelium in pericyte-deficient mice
(Figure 3E). In mice exhibiting substantial loss of pericytes, the
IgG accumulates were also found in some remaining pericytes,
as illustrated in an 8-month-old F7 mouse (Figure 3F), in contrast
to controls.
Pdgfrb+/ mice exhibited an age-dependent increase in peri-
vascular fibrin (Figures 4A–4C), which was shown to accelerate
neurovascular damage (Paul et al., 2007). Quantification of
perivascular fibrin deposits in Pdgfrb+/mice compared to con-
trols indicated 6-, 10-, and 46-fold increase at 1, 6–8, and
14–16 months of age, respectively, as shown in the cortex (Fig-
ures 4A–4C), and similar age-dependent increases in the hippo-
campus (Figures S2D–S2F). An increased fibrin leakage of
approximately 25- to 30-fold was found in the cortex and
hippocampus, in 6- to 8-month-old F7 mutants (Figure 4C). As
for IgG, there was a significant negative correlation between
fibrin perivascular accumulation in brain and pericyte coverage
(Figure 4D and Figure S2F). Fibrin accumulation was particularly
abundant around brain capillaries lacking pericyte coverage
(Figure 4E). Fibrin was also found in endothelial cells (Fig-
ure 4E) and pericytes, as shown in F7 mice (Figure 4F), but
was leaking from the adjacent capillaries without pericyte cover-
age, as illustrated in Figure 4F (lower right corner).
To determine whether loss of pericytes can lead to patholog-
ical accumulations of neurotoxic macromolecules, we studied
the brains of 6- to 8-month-old Pdgfrb+/ and F7 mice for
(1) hemosiderin deposits reflecting extravasation of the red
blood cells with accumulation of hemoglobin-derived neurotoxic
products such as iron that damages neurons by generating
reactive oxygen species (Zhong et al., 2009); (2) accumulation
of thrombin, which at higher concentrations mediates neurotox-
icity and memory impairment (Mhatre et al., 2004) and vascular
damage and BBB disruption (Chen et al., 2010); and (3) plasmin
(derived from circulating plasminogen), which catalyzes the
degradation of neuronal laminin promoting neuronal injury
(Chen and Strickland, 1997). As shown by Prussian blue stain-
ing, Pdgfrb+/ mice and the F7 mutants exhibited 5- and
8-fold greater hemosiderin accumulation than controls, respec-
tively (Figure 4G). Immunoblot analysis of capillary-depleted
brains revealed that Pdgfrb+/ mice and the F7 mutants accu-
mulate 21 and 46 times more thrombin than controls, respec-
tively (Figure 4H, upper lane, left graph). These mice also
showed 17 and 39 times greater accumulation of plasmin
compared to controls, respectively, accompanied with a propor-
tional reduction in laminin content in capillary-depleted brain
(Figure 4H, middle and lower panels and middle and right
graphs). These findings show that pericyte loss leads to BBB
breakdown and accumulation of vasculotoxic and neurotoxic
macromolecules in brain that is proportional to the degree of
pericyte loss.
To test whether the BBB is open to acutely administered
exogenous macromolecules, we performed in vivo time-lapse
multiphoton imaging of the cortical vessels in layers II and III
with intravenous medium-size macromolecular dextran (MW =
40,000 Da, tetramethylrhodamine [TMR] conjugated) in 1-, 6-
to 8-, and 14- to 16-month-old Pdgfrb+/ mice. In contrast toNeuron 68, 409–427, November 4, 2010 ª2010 Elsevier Inc. 413
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Figure 3. Age-Dependent BBB Disruption to Plasma Proteins in Pericyte-Deficient Mice
(A) Confocal microscopy analysis of plasma-derived IgG (red) and fluorescein-conjugated lectin-positive microvessels (green) in the hippocampus of an 8-month-
old Pdgfrb+/+ and in 1-, 8-, and 16-month-old Pdgfrb+/ mice. Arrows indicate extravascular IgG deposits.
(B and C) Quantification of extravascular IgG deposits in the hippocampus of 1-month-old Pdgfrb+/mice (black bar) and Pdgfrb+/+ controls (white bar) (B) in 6- to
8- and 14- to 16-month-old Pdgfrb+/ mice (black bars) and Pdgfrb+/+ controls (white bars) and in 6- to 8-month-old F7 mice (gray bar) (C). In (B) and (C),
24 randomly chosen fields (420 3 420 mm) within the hippocampus were analyzed from six nonadjacent sections per mouse. Values are mean ± SEM, n = 6
mice per group; *p < 0.05 or **p < 0.01 by one-way ANOVA. (See Figure S2).
(D) Negative correlation between an age-dependent IgG brain accumulation and loss of pericyte capillary coverage in the hippocampus of Pdgfrb+/mice. Single
data points were from 1- (red), 6- to 8- (blue), and 14- to 16-month-old (black) Pdgfrb+/ mice (n = 18). r = Pearson’s coefficient.
(E) Confocal microscopy imaging of IgG deposits (green) around lectin-positive capillaries (white) lacking pericyte coverage (red; negative desmin staining) in an
8-month-old Pdgfrb+/ mouse. Orthogonal views suggest that microvessels lacking pericyte coverage have significant perivascular IgG accumulation.
(F) Confocal microscopy analysis of IgG (green) and a pericyte marker PDGFRb (red) on lectin-positive (blue) pericyte-covered capillary in an 8-month-old F7
mutant mouse. Orthogonal views show IgG accumulation in a PDGFRb-positive pericyte in a F7 mouse.
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the 30 min period of imaging, there was a rapid age-dependent
in vivo leakage of TMR-dextran in Pdgfrb+/ mice in all age
groups, beginning at 10 min and peaking at 30 min (Figure 5A).
The leakage was obvious in 1-month-old Pdgfrb+/ mice indi-
cating 3-fold increase in the cerebrovascular permeability414 Neuron 68, 409–427, November 4, 2010 ª2010 Elsevier Inc.(i.e., the permeability surface area product [PS]) compared
to controls (Figure 5B), and 19- and 54-fold greater PS value in
6- to 8- and 14- to 16-month-old Pdgfrb+/ mice compared to
their respective age-matched controls (Figure 5C). There was
a significant30-fold increase in the PS product to TMR-dextran
in the F7 mutants (Figure 5C). The degree of BBB leakage to
Neuron
Pericytes Control Adult Neurovascular Functiondextran in Pdgfrb+/mice was proportional to the degree of peri-
cyte loss (Figure 5D).
To increase confidence in our in vivo time-lapse multiphoton
data and find out whether an acute 30min cranial window proce-
dure for the multiphoton imaging affects BBB permeability
measurements, we next used a noninvasive fluorometric anal-
ysis, which did not require the cranial window surgical manipula-
tion, to determine BBB permeability to TMR-dextran in 6- to
8-month-old Pdgfrb+/ mice and F7 mutants. This noninvasive
fluorescent technique confirmed an increased BBB permeability
to TMR-dextran (MW = 40,000 Da) in Pdgfrb+/ mice and F7
mutants in the cortex by 18- and 30-fold, respectively (Figure 5E).
These results were comparable to the results obtained by in vivo
multiphoton imaging, indicating no discrepancy between the
methods. The BBB breakdown was also seen in the hippo-
campus (Figure 5E) and other brain regions (data not shown).
To determine the molecular size limit of solutes that can
penetrate through the abnormal BBB in the mutant mice, we
studied the BBB permeability to Cy3-IgG (MW = 150,000 Da),
FITC-dextran (MW = 500,000 Da), and fluorescein-mega-
dextran (MW = 2,000,000 Da) in 6- to 8-month-old Pdgfrb+/+,
Pdgfrb+/, and F7 mice by using a noninvasive fluorometric
method. These measurements have indicated that the BBB is
open to molecules ranging from 40,000 to 500,000 Da; the
molecular size limit was found to be between 500,000 and
2,000,000 Da (Figure 5E). These data suggest that molecules
such as thrombin (MW = 36,000 Da) and fibrinogen (MW =
340,000 Da) can enter freely from the circulation into the brain
across the damaged BBB and accumulate in the brain.
BBB breakdown within a short period of time, as observed as
in the present BBB permeability studies, typically indicates
disruption of the BBB tight junctions (TJ) (Zlokovic, 2008). TJ
proteins seal the endothelial barrier preventing uncontrolled
entry of solutes from blood to brain. Their expression is reduced
in stroke and several neurodegenerative disorders leading to the
BBB breakdown (Zlokovic, 2008). TJ appearance in the embry-
onic CNS is associated with pericyte coverage of the endothe-
lium (Bauer et al., 1993), and pericytes enhance the endothelial
barrier integrity in vitro (Nakagawa et al., 2007; Kro¨ll et al.,
2009). Therefore, we tested whether TJ expression is altered in
pericyte-deficient mice. Immunoblot analysis of TJ proteins in
isolated brain capillaries revealed an age-dependent reduction
in ZO-1 and occludin expression in Pdgfrb+/ mice compared
to controls by 40%–50% and 80% in 6- to 8- and 14- to
16-month-old mice, respectively (Figure 5F-H). A comparison
of ZO-1, occludin, and claudin-5 expression in 6- to 8-month-
old Pdgfrb+/ mice and F7 mutants has revealed significant
reductions by 48% and 37%, 42% and 80%, and 69% and
70%, respectively, compared to controls (Figures S3A and
S3B). These findings were corroborated by immunostaining for
the TJ protein ZO-1 (Figures S3C and S3D) and the adherens
junction protein VE-cadherin (Figures S3E and S3F). Pericyte-
deficient mice also exhibited reductions in the capillary base-
ment membrane proteins collagen IV and vascular laminin, as
shown by immunoblotting of the isolated brain microvessels
(Figures S3G and S3H), consistent with the role of pericytes
in basement membrane formation (Dı´az-Flores et al., 2009).
In addition, accumulation of different endogenous macromole-cules in brain endothelium of pericyte-deficient mice as shown
for IgG (Figures 3E and 3F) and fibrinogen/fibrin (Figures 4E
and 4F) might reflect enhanced bulk flow transcytosis that may
also contribute to the observed BBB disruption.
To determine whether accumulation of blood-derived compo-
nents in the brain is primarily related to pericyte deficiency and
not to perfusion stress, we studied mice with a single deletion
of the mesenchyme homeobox gene-2 allele (Meox2+/) exhibit-
ing a significant perfusion deficit with 45%–50% reductions in
capillary density and resting CBF, respectively, as we reported
(Wu et al., 2005), but with normal pericyte coverage of microves-
sels (Figures S4A and S4B). In contrast to F7 or Pdgfrb+/ mice,
Meox2+/mice at a comparable age did not show any extravas-
cular IgG or fibrin deposits (Figure S4C) and expressed normal
levels of TJ proteins (Figure S4D) in spite of significant (p <
0.05) 45% and 48% reductions in the microvascular length
(Figure S4E) and brain perfusion (data not shown), as reported
(Wu et al., 2005). Studies in Meox2+/ mice confirmed that the
BBB breakdown in pericyte-deficient mice is not related to
perfusion stress and is mediated by pericyte loss. Meox2+/
mice had normal arterial vascular reactivity and normal thickness
of the vascular smooth muscle cells layer in the pial arteries
(Wu et al., 2005), consistent with unaltered CBF responses to
stimulation (Figure S4F) further supporting that pericytes are
required for hemodynamic responses to brain activation.
Dual fluorescent staining of lectin-positive endothelium and
aquaporin 4 or a-syntrophin (SNTA1), markers of the astrocytic
end-foot processes enwrapping brain microvessels, and glial
fibrillary acidic protein (Zlokovic, 2008), failed to show changes
in astrocyte coverage of microvessels and astrocyte number in
pericyte-deficient mice, respectively (Figure S5). These findings
are consistent with earlier studies demonstrating that TJ forma-
tion at the BBB does not require contact with astrocyte foot
processes on capillary surface and is not affected in areas lack-
ing astrocytes (reviewed in Zlokovic, 2008).
Neurodegeneration and Impairments in Learning
and Memory in Pericyte-Deficient Mice
To determine whether loss of pericytes causing alterations
in microvascular function and BBB integrity was sufficient to
induce irreversible neuronal injury, we studied neuronal mor-
phology and behavior.
Using Golgi-Cox staining, we failed to detect any structural
changes in neurons in the CA1 hippocampal region (or cortex,
data not shown) in 1-month-old Pdgfrb+/ mice (Figures 6A–
6E). However, there was a significant age-dependent loss of
dendritic length, spine density, and spine length in the hippo-
campus of Pdgfrb+/ mice at 6–8 and 14–16 months of age by
32%, 30%, and 18%, and 55%, 58%, and 56%, respectively
(Figures 6A–6E). A comparison of 6- to 8-month-old Pdgfrb+/
and F7 mice indicated significantly greater changes in neuronal
morphology in the CA1 hippocampus region (Figures 6C–6E)
and cortex (data not shown) in F7 mice.
Histological staining of the hippocampus CA1 stratum pyrami-
dale indicated a moderate and substantial loss of neurons in
6-month-old Pdgfrb+/ and F7 mice, respectively, compared to
a control Pdgfrb+/+ mouse (Figure 6F). Counting of NeuN-posi-
tive neurons in the CA1 stratum pyramidale corroborated noNeuron 68, 409–427, November 4, 2010 ª2010 Elsevier Inc. 415
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Figure 4. Pathologic Accumulations in Brains of Pericyte-Deficient Mice
(A) Confocal microscopy analysis of fibrin (green) and CD31-positive microvessels (red) in the cortex of an 8-month-old Pdgfrb+/+ and 1-, 8-, and 16-month-old
Pdgfrb+/ mice. Arrows indicate extravascular fibrin deposits.
(B and C) Quantification of fibrin extravascular deposits in the cortex of 1-month-old Pdgfrb+/+ (white bar) and Pdgfrb+/mice (black bar) (B), and 6- to 8- and 14-
to 16-month-old Pdgfrb+/+ (white bars) and Pdgfrb+/mice (black bar), and 6- to 8-month-old F7 mice (gray bar) (C). In B and C, 36 randomly chosen fields (4203
420 mm) in the cortex were analyzed from six nonadjacent sections per mouse. Values are mean ± SEM, n = 6 mice per group; *p < 0.05 or **p < 0.01 by one-way
ANOVA (see Figure S2).
(D) Negative correlation between an age-dependent fibrin extravascular accumulation and loss of pericyte coverage in the cortex of Pdgfrb+/mice. Single data
points derived from 1 (red), 6- to 8- (blue), and 14- to 16-month-old (black) Pdgfrb+/ mice (n = 18). r = Pearson’s coefficient.
(E) Confocal microscopy imaging of fibrin deposits (green) around lectin-positive capillary (white) lacking desmin-positive (red) pericyte coverage in an 8-month-
old Pdgfrb+/ mouse. The orthogonal views show a significant perivascular fibrin accumulation.
(F) Confocal microscopy imaging of fibrin (green) and a pericyte marker PDGFRb (red) covering a lectin-positive capillary (blue) in an 8-month-old F7 mutant
mouse. Orthogonal views show fibrin accumulation in a PDGFRb-positive pericyte in a F7 mouse.
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Pericytes Control Adult Neurovascular Functionloss in 1-month-old Pdgfrb+/mice, and a 10% and 27% loss in
6- to 8-month-old Pdgfrb+/ and F7 mice, respectively (Fig-
ure 6G). Pdgfrb+/ 14- to 16-month-old mice had a significantly
greater (48%) loss of neurons in the CA1 region compared to
controls (Figure 6G). Confocal microscopy analysis for TUNEL,
neuronal marker NeuN and thrombin in 6-month-old and older
Pdgfrb+/ mice indicated sporadically a colocalization of the
cytoplasmic thrombin accumulations and TUNEL-positive dying
neurons, as illustrated in an 8-month-old Pdgfrb+/ mouse
compared to negative staining for TUNEL and thrombin in a
control Pdgfrb+/+ mouse (Figure 6H).
Using the Hypoxyprobe-1 (pimonidazole), we found that brains
of 6- to 8-month-old Pdgfrb+/ and F7 mice are hypoxic com-
pared to control Pdgfrb+/+ mice (Figure 7A).The hypoxic area
expressed as a percentage of total tissue area in the hippo-
campus and cortex was 1.5% in control Pdgfrb+/+ mice com-
pared to 6%–7% in Pdgfrb+/ mice and 9%–11% in F7 mutants
(Figure 7B). Chronic hypoxic changes in brain tissue probably
aggravate neuronal injury, as shown in models of combined
ischemic/hypoxic brain injury (Ten et al., 2004). No significant
hypoxic changes were found in young pericyte-deficient mice
(data not shown). It is of note that the brains of pericyte-deficient
mice were perfused with fully oxygenated arterial blood under
normal arterial systolic/diastolic perfusion pressure (see Anal-
ysis of Systemic Parameters below), suggesting brain hypoxic
changes are related to reductions in brain microcirculation and
CBF, rather than to systemic hemodynamic insufficiency.
Notably, vascular injury is well established at the 1 month time
point in the absence of neuronal changes, thereby suggesting
that a primary vascular injury precedes neuronal injury at later
time points in pericyte-deficient mice. Significantly, 6-month-
old Meox2+/ mice with an intact BBB (Figure S4), but compa-
rable microvascular reductions and perfusion stress (Wu et al.,
2005) as pericyte-deficient F7 mice at the same age, showed
a significant reduction in SMI-32-positive neuritic density in the
hippocampus CA1 stratum radiatum and cortex and a significant
loss of neurons from the hippocampus CA1 stratum pyramidale
and cortex by 25% and 19%, and 13% and 14%, respectively,
compared to the corresponding values in Meox2+/+ controls
(Figures 8A–8D). However, neuronal changes in Meox2+/ mice
were much less pronounced than the reduction in the neuritic
length and neuronal loss seen in the same regions of F7 mice
that were 50% and 46%and 25%and 26%, respectively, of their
corresponding controls (Figures 8A–8D). These data suggest
that perfusion stress alone is sufficient to induce neuronal
injury but may act in synergy with accumulated neurotoxins
secondary to BBB breakdown to induce even greater injury, as
evidenced by more severe neuronal changes in pericyte-defi-
cient mouse models.
Significantly, 1-month-old Pdgfrb+/ mice did not show
changes in hippocampal learning and spatial memory deter-(G) Quantification of Prussian blue-positive hemosiderin deposits in sagittal brain
compared to age-matched Pdgfrb+/+ controls. (Inset) A hemosiderin deposit in the
were analyzed per mouse.
(H) Immunoblotting of thrombin, plasmin, and laminin in capillary-depleted brai
as a loading control. Graphs show quantification of relative protein abundance
or **p < 0.01 by one-way ANOVA.mined by novel object location (Mumby et al., 2002) (Figure 6I)
and the perirhinal cortex-mediated consolidation of novel object
recognition memory (Winters and Bussey, 2005) (Figure 6J),
consistent with intact neuronal circuitries mediating these
behavioral responses at the time point when these mice have
accumulated significant vascular damage including BBB break-
down and perfusion deficit. In contrast, 6- to 8- and 14- to
16-month-old Pdgfrb+/ mice had significant impairments on
both tests (Figures 6I–6J). F7 mutants had worse performance
on both tests compared to Pdgfrb+/ mice (Figures 6I–6J).
To verify functional neuronal integrity in young Pdgfrb+/mice,
wemeasured local field potentials (LFP) in layer II of the hind limb
somatosensory cortex and blood flow responses following
electrical stimulation of the hind limb. We did not find significant
differences in the LFP amplitude curves in response to an
increasing electrical stimulus, LFP peak amplitudes, time-to-
peak values, and/or LFP signals integrated over the time period
of activation (SLFP) between 1-month-old Pdgfrb+/ and
Pdgfrb+/+ mice (Figure S6A–S6F). On the other hand, there was
a significant 23% diminished CBF response in the hind limb
somatosensory cortex in 1-month-old Pdgfrb+/mice compared
to controls (Figure S6G), corroborating our finding showing
reduced CBF response in young Pdgfrb+/ mice after vibrissal
stimulation (Figure 2F).
Late Neuroinflammatory Response
in Pericyte-Deficient Mice
Finally, we studied the role of neuroinflammation. To determine
whether the number of microglia is increased, we performed
immunostaining for Iba1 (ionized calcium binding adaptor
molecule 1), which has been used to study microglial cells in
models of neurodegenerative diseases including superoxide-
dismutase-1 mutant mice (Boille´e et al., 2006) or microglial
neurotoxicity (Cardona et al., 2006). Pdgfrb+/ mice at 1 and
6–8 months did not show a significant neuroinflammatory
response (Figure 9). At 16 months of age, however, Pdgfrb+/
mice had a significant 2.5-fold increase in the number of micro-
glia displaying a larger ameboid form with stubby processes
suggestive of activated microglia compared to the resting
microglia with smaller bodies and thinner processes that were
found in controls and 1- and 8-month-old Pdgfrb+/ mice
(Figures 9A–9B). Specific staining for neutrophils (granulocytes)
was negative in brains of 1- and 6- to 8-month-old Pdgfrb+/
mice and showed a nonsignificant increase to 1.2 neutrophils
per mm2 in 16-month-old mice (Figures 9C–9D). Consistent
with microglia activation, 16-month-old, but not 1- and 6- to
8-month-old, Pdgfrb+/ mice exhibited a significant (p < 0.05)
increase in the expression of several inflammatory cytokines,
including interleukin 1b and 6, tumor necrosis factor-a, mono-
cyte chemoattractant protein-1, and intercellular adhesion
molecule 1 (Figures 9E–9I).sections of cortex plus hippocampus of 8-month-old Pdgfrb+/ and F7 mice
cortex of an 8-month-old Pdgfrb+/mouse. A total of six nonadjacent sections
n tissue of 8-month-old Pdgfrb+/+, Pdgfrb+/, and F7 mice. b-actin was used
with densitometry analysis. Mean ± SEM, n = 6 animals per group; *p < 0.05
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Figure 5. BBB Breakdown to Exogenous Dextran in Pericyte-Deficient Mice
(A) In vivo time-lapsemultiphoton imaging of TMRdextran (MW=40,000; red) leakage from cortical vessels (layer II and III, approximately 100 mm from the cortical
surface) in an 8-month-old Pdgfrb+/+ mouse, and 1-, 8-, and 16-month-old Pdgfrb+/ mice within 30 min of TMR-dextran intravenous administration.
(B andC) The cerebrovascular PS for TMR-dextran (40,000 Da) determined bymultiphoton imaging as in (A) in 1-month-oldPdgfrb+/mice (black bar) and control
Pdgfrb+/+ (white bar) mice (B), and 6- to 8- and 14- to 16-month-old Pdgfrb+/ (black bar) and control Pdgfrb+/+ (white bars) mice, and 6- to 8-month-old F7 mice
(gray bar) (C).
(D) Negative correlation between the PS product for TMR-dextran and age-dependent loss of pericyte coverage of cortical capillaries in Pdgfrb+/mice. Single
data points derived from 1 (red), 6- to 8- (blue), and 14- to 16-month-old (black) Pdgfrb+/ mice (n = 18). r = Pearson’s coefficient.
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In all studied genotypes and ages, we have measured hemody-
namic and other physiologic parameters including: (1) mean
arterial blood pressure from the femoral artery; (2) systolic and
diastolic blood pressure; (3) pulse arterial pressure (difference
between systolic and diastolic pressure); (4) heart rate; (5) arterial
blood gases; (6) arterial pH; (7) serum and CSF glucose levels,
and (8) respiration rate. In addition, we have determined in 6-
to 8-month-old mice in all genotypes (i.e., Pdgfrb+/+, Pdgfrb+/,
and F7 mice): (9) liver analyses, and (10) kidney analyses (see
Figure S7).
These data show no statistical difference in any of the mea-
sured hemodynamic, physiological, and/or biochemical param-
eters including tests for the liver and kidney functions between
Pdgfrb+/ and F7 mice compared to age-matched control
Pdgfrb+/+mice, suggesting that pericyte-deficient mice do not
have a general perfusion deficit and/or an apparent cardiovas-
cular insufficiency. This indicates that brain perfusion deficits in
these mice are mainly of local character.
DISCUSSION
We show that deficient PDGFRb signaling results in pericyte
degeneration in the adult and aging brain leading to reductions
in brain microcirculation and BBB breakdown prior to neurode-
generation and neuroinflammation (Figure 10). Although the
mouse lines used in the present study were not pericyte specific,
changes in neuronal structure and function in the present peri-
cyte-deficient models on a 129S1/Sv1mJ background cannot
be explained by primary neuronal injury because PDGFRb is
not expressed in neurons in these mice (Winkler et al., 2010).
Our findings are consistent with previous reports showing that
129SV/C57BL6 mice do not express PDGFRb in neurons or
other cell types within the neurovascular capillary unit and that
loss of PDGF-B/PDGFRb signaling due to global PDGF-B and/
or PDGFRb knockouts results in vascular damage in the devel-
oping CNS mediated by pericyte loss, not neuronal loss (Lindahl
et al., 1997; Hellstro¨m et al., 1999). Moreover, gene expres-
sion profiling on acutely isolated neurons from C57BL6 and
C57BL6/DBA mice failed to detect Pdgfrb expression (Cahoy
et al., 2008; http://innateimmunity.mit.edu/cgi-bin/exonarray/
plot_selector_cahoy.pl).
Other studies have suggested that PDGFRb is expressed in
cultured neurons (Zheng et al., 2010) and in the brains of
C57BL6 mice and have proposed that higher susceptibility of
nestin-Cre+PDGFRbflox/flox mice to cryogenic injury is due to
a selective neuronal vulnerability caused by Pdgfrb deletion (Ishii
et al., 2006). The source of the contradictions between these
reports remains unclear. It is possible, however, that these con-(E) The BBB permeability PS product for TMR-dextran (40,000 Da), Cy-3-IgG (150
dextran (MW = 2,000,000 Da) in 6- to 8-month-old Pdgfrb+/+ (white bar), Pdgfrb+/
tissue analysis not requiring the cranial window surgical procedure. Mean ± SEM
used as an abbreviation for nondetectable.
(F) Immunoblotting of ZO-1 and occludin in isolated cortical and hippocampal cap
old Pdgfrb+/ mice.
(G and H) Quantification of ZO-1 (G) and occludin (H) relative abundance by den
Pdgfrb+/ mice showing a progressive decrease in the tight junction proteins in
(B), (C), (G), and (H), mean ± SEM, n = 6 animals per group. *p < 0.05 or **p < 0.flicting results may reflect genetic differences between mouse
strains, consistent with strain-specific gene expression in the
adult mouse CNS (Silva et al., 1997; Sandberg et al., 2000).
In addition, cultured neurons do not accurately represent the
transcriptional profile of neurons in vivo (Tosh and Slack, 2002;
Liu et al., 2007) or of acutely isolated noncultured neurons
(Cahoy et al., 2008). A recent finding that brain pericytes express
nestin (Dore-Duffy et al., 2006) suggests nestin-Cre genetic
manipulation probably deletes PDGFRb from pericytes, which
complicates data interpretation in nestin-Cre+PDGFRbflox/flox
mice (Ishii et al., 2006). The generation of pericyte-specific
Pdgfrß knockout mouse lines will be helpful to confirm that
the neuronal phenotype caused by deficient PDGFRb signaling
depends on pericyte loss causing secondary vascular-mediated
neurodegeneration, as suggested by the present models.
The threshold for pericyte loss required to trigger neurovascu-
lar dysfunction and/or neurodegeneration during brain aging
could not be easily predicted based on earlier work. We show
that a modest 20% loss in pericytes coverage can initiate vas-
cular damage in 1-month-old Pdgfrb+/ mice, as indicated by
significant microvascular reductions and disruption of the BBB.
This moderate reduction in pericyte coverage, however, did
not produce neuronal damage. Somewhat greater, 40% loss in
pericyte coverage in 6- to 8-month-old Pdgfrb+/ mice resulted
in a profound neurovascular insufficiency, changes in neuronal
structure, and impairments in behavior. Moreover, Pdgfrb+/
mice show a quantitative relationship between an age-depen-
dent progressive pericyte loss and the reductions in brain capil-
lary density, resting CBF and CBF responses to brain activation,
and the BBB breakdown associated with brain accumulation of
serum proteins and several potentially cytotoxic and/or neuro-
toxic macromolecules (e.g., fibrin, hemosiderin, thrombin, and
plasmin). Vascular, neuronal, and behavioral changes were
more pronounced in F7 mice expressing greater pericyte loss
than Pdgfrb+/ mice, confirming a key role of pericytes in main-
taining integrity of the neurovascular unit.
Our findings were quite unexpected given that loss of a single
Pdgfrb allele does not result in an apparent vascular phenotype
or CNS defects in the developing CNS (Leve´en et al., 1994; Sor-
iano, 1994; Lindahl et al., 1997; Tallquist et al., 2003) and that
pericytes in the embryonic CNS do not regulate microvessel
density and length but are involved in the regulation of endothe-
lial cell number and microvessel architecture (Lindahl et al.,
1997; Hellstro¨m et al., 1999, 2001). Although, our data suggest
that pericytes may fulfill a different regulatory role with respect
to the brain microcirculation during postnatal development and
adulthood and during the aging process than previously
observed during prenatal embryonic development, the exact
contribution of embryonic pericyte loss to the observed,000 Da), FITC-dextran (MW = 500,000 Da), and fluorescein-conjugated mega-
 (black bar), and F7 (gray bar) mice determined by a noninvasive fluorometric
, n = 4–6 animals per group. *p < 0.05 or **p < 0.01 by one-way ANOVA. ND is
illaries from a 16-month-old Pdgfrb+/+ control mouse and 1-, 8-, and 16-month-
sitometry analysis of immunoblots in 1-, 8-, and 16-month-old Pdgfrb+/+ and
the aging pericyte-deficient mice. b-actin was used as a loading control. In
01 by one-way ANOVA (see Figures S3–S5).
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Figure 6. Age-Dependent Neurodegeneration and Impairments in Memory and Learning in Pericyte-Deficient Mice
(A and B) Low-magnification bright-field microscopy analysis of Golgi-Cox staining of neurons (A) and high-magnification bright-field microscopy images of
dendritic spine density (B) in the CA1 region of the hippocampus of an 8-month-old Pdgfrb+/+ control and 1-, 8-, and 16-month-old Pdgfrb+/ mice.
(C–E) Dendritic length (C), dendritic spine density (D), and spine length (E) of Golgi-Cox stained neurons in the CA1 region of the hippocampus in 1, 6- to 8-, and
14- to 16-month-old Pdgfrb+/ mice (black bars) and control Pdgfrb+/+ (white bars) mice, and 6- to 8-month-old F7 mice (gray bars). A total of 30 fields (500 3
375 mm) from three adjacent 100 mm thick sections were analyzed per mouse for dendritic length measurements. A total of 100 randomly selected dendrites from
three adjacent 100 mm thick sections were analyzed per mouse for dendritic spine density measurements and for spine length quantification.
(F) Bright-field microscopy analysis of hemotoxylin and eosin staining of stratum pyramidale in the CA1 hippocampal region of 6-month-old Pdgfrb+/+, Pdgfrb+/,
and F7 mice.
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A B Figure 7. Hypoxic Brain Tissue Changes in
Pericyte-Deficient Mice
(A) Confocal analysis of hypoxyprobe-1 (pimoni-
dazole)-positive hypoxic (O2 < 10 mm Hg) tissue
in the hippocampus of 8-month-old Pdgfrb+/+,
Pdgfrb+/, and F7 mice.
(B) Quantification of hypoxyprobe-1-positive area
expressed as a percentage of total tissue area in
the cortex and hippocampus of 6- to 8-month-
old Pdgfrb+/+, Pdgfrb+/, and F7 mice. A total of 36
and 24 randomly chosen fields (420 3 420 mm)
from six nonadjacent cortical and hippocampal
sections, respectively, were analyzed per mouse.
Mean ± SEM, n = 6 mice per group; *p < 0.05 or
**p < 0.01 by one-way ANOVA (see Figure S7).
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or Pdgfrb promoter-dipthera toxin construct, and/or a pericyte-
specific genetic model with postnatal Pdgfrb deletion with either
one being induced in the adult life, may help address: (1) whether
loss of pericytes early in the developing CNS (as shown by Tall-
quist et al., 2003) evolves exponentially over time and becomes
the primary force driving the loss of CNS microvascular homeo-
stasis; and (2) whether there is a major difference in the response
of the embryonic CNS versus the adult and aging brain to
pericyte loss. The feasibility of creating mouse lines with induc-
ible deletion of Pdgfrb gene to address the above questions
remains to be determined by future studies.
Deficient PDGF-B/PDGFRb signaling has been shown to
initiate pericyte apoptosis leading to vascular regression in
animal models of diabetic retinopathy (Geraldes et al., 2009)
and tumors (Song et al., 2005). Cellular accumulation of different
toxins such as oxidized glycated low-density lipoproteins (Diffley
et al., 2009), amyloid beta-peptide (Wilhelmus et al., 2007) or
advanced glycation end products (Alikhani et al., 2010) can
also trigger pericyte apoptosis as shown in pericyte cultures.
We show that a deficient PDGFRb signaling in the adult and
aging brain in Pdgfrb+/ and F7 mice leads to pericyte-specific
insult and apoptosis resulting in microvascular degeneration.
Although the mechanism of age-dependent vascular pruning in
pericyte-deficient mice is unknown, it may reflect a loss of peri-
cyte-derived trophic support, including vascular endothelial
growth factor (Bondjers et al., 2006). The observed cellular accu-
mulation of serum proteins and cytotoxic macromolecules prob-
ably accelerates pericyte degeneration, consistent with in vitro
studies.
The exact contributions of perfusion stress and BBB disrup-
tion to the development of neurodegenerative changes is not
well understood at present. In our study, Meox2+/ mice with
normal pericyte coverage and an intact BBB, but with a substan-
tial perfusion deficit (Wu et al., 2005) comparable to that in peri-
cyte-deficient mice, showed less pronounced changes in(G) Quantification of NeuN-positive neurons in the stratum pyramidale of the CA1
bars) and control Pdgfrb+/+ (white bars) mice, and 6- to 8-month old F7 mice (gra
campus were analyzed from six nonadjacent sections per mouse.
(H) Confocal microscopy analysis of TUNEL (green), NeuN-positive neuronal nu
control Pdgfrb+/+ mouse.
(I and J) Novel object location (I) and novel object recognition (J) exploratory pref
age-matched Pdgfrb+/+ control mice (white bars) and in 6- to 8-month-old F7 mi
In (C–E, G, and I and J), mean ± SEM, n = 6–10 mice per group; *p < 0.05 by onneuronal structure than pericyte-deficient mice, indicating that
chronic perfusion alone can cause neuronal injury but not to
the extent as when combined with the BBB breakdown. Recent
findings have suggested that cultured human brain pericytes
express low but comparable levels of neurotrophic factors as
cultured astrocytes (Shimizu et al., 2010). Given that the expres-
sion and role of pericyte-derived neurotrophic factors in brain
in vivo have not been demonstrated and that pericytes do not
make direct contacts with neurons (in contrast to astrocytes)
(Zlokovic, 2008), it is unclear at present whether pericyte degen-
eration can increase neuronal susceptibility to injury through
diminished neurotrophic support.
Perfusion stress and BBB compromise have been associated
with neurodegenerative disorders (Zlokovic, 2008), including Alz-
heimer’s disease (Iadecola et al., 1999; Deane et al., 2003; Chow
et al., 2007; Bell et al., 2009) and amyotrophic lateral sclerosis
(Zhong et al., 2008, 2009; Rule et al., 2010). Our work in progress
shows that a pericyte-restrictedpattern of PDGFRb expression is
associated with pericyte loss in Alzheimer’s disease (E.A.W.,
R.D.B., and B.V.Z., unpublished data) indicating that pericyte-
deficient mice could potentially be used to study the role of brain
pericytes in the development of human neurodegenerative
conditions such as Alzheimer’s disease or amytrophic lateral
sclerosis. A temporal sequence of events in the present study
suggests that degeneration of vascular pericytes can initiate
circulatory insufficiency and BBB disruption first, that is followed
by secondary neurodegenerative changes. This vascular con-
cept of neurodegeneration could have broader implications for
our understanding of neurological disorders and might guide
new therapeutic approaches directed at brain pericytes.EXPERIMENTAL PROCEDURES
Animals
Pdgfrb+/ and F7mice were generated as previously described (Tallquist et al.,
2003) and kindly provided by Dr. Philippe Soriano. For the Pdgfrb+/ mice,hippocampal subfield in 1-, 6- to 8-, and 14- to 16-month-old Pdgfrb+/ (black
y bar). A total of 24 randomly chosen CA1 fields (420 3 420 mm) in the hippo-
clei (red), and thrombin (blue) in the cortex of an 8-month-old Pdgfrb+/ and
erence in 1-, 6- to 8-, and 14- to 16-month-old Pdgfrb+/mice (black bars) and
ce (gray bars) (see Figure S6).
e-way ANOVA. NS is used as an abbreviation for nonsignificant.
Neuron 68, 409–427, November 4, 2010 ª2010 Elsevier Inc. 421
A B
DC
Figure 8. Neurodegenerative Changes in
Meox2+/– and F7 Mice
(A) Confocalmicroscopy analysis of SMI-32 immu-
nodetection of neurites (green) and TO-PRO3
nuclear staining (blue) in the hippocampus of 8-
month-old Pdgfrb+/+ and F7 and Meox2+/+ and
Meox2+/ mice. The following abbreviations are
used: Pyr., stratum pyramidale and Rad., stratum
radiatum.
(B) Quantification of SMI-32 positive neurite den-
sity in the cortex and hippocampus of 8-month-
old Pdgfrb+/+ and F7 and Meox2+/+ and Meox2+/
mice.
(C) Confocal microscopy analysis of NeuN-posi-
tive neurons (green) in the cortex in 8-month-old
Pdgfrb+/+ and F7 and Meox2+/+ and Meox2+/
mice.
(D) Quantification of NeuN-positive neurons in
the cortex and hippocampus CA1 stratum pyrami-
dale of 8-month-old Pdgfrb+/+ and F7 mice and
Meox2+/+ and Meox2+/ mice.
In (B and D), a total of 36 and 24 randomly chosen
fields (4203 420 mm) from six nonadjacent cortical
and hippocampal sections, respectively, were
analyzed per mouse. Mean ± SEM, n = 6 mice per
group; *p < 0.05 or **p < 0.01 by one-way ANOVA.
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Pericytes Control Adult Neurovascular Functiona PGKneobpA expression cassette was used to replace a 1.8 kb genomic
SmaI-EcoRV fragment spanning sequences coding for the signal peptide to
the second immunoglobulin domain of PDGFRb. The F7 mice were generated
by point mutations that disrupt the following residues and designated signal
transduction pathways: residue 578 (Src), residue 715 (Grb2), residues 739
and 750 (PI3K), residue 770 (RasGAP), and residue 1008 (SHP-2); by changing
the tyrosine to phenylalanine, and residue 1020 PLCg, in which the tyrosine
was mutated to encode an isoleucine. The Pdgfrb+/ and F7 embryos have
a significant (35%–40% and 55%–75%, respectively) reduction in pericytes
in the neural tube at the level of heart and kidney in coronal sections at
E14.5 (Tallquist et al., 2003).Meox2+/mice were generated as we previously
described (Wu et al., 2005). All mice were maintained on a 129S1/SvlmJ back-
ground and were shown to express PDGFRb in the brain exclusively in peri-
cytes (Winkler et al., 2010). All procedures were approved by the Institutional
Animal Care and Use Committee at the University of Rochester with National
Institutes of Health guidelines.
Tissue Immunofluorescent and Fluorescent Lectin Staining
Micewereanesthetized intraperitoneallywith100mg/kgketamineand10mg/kg
xylazine and transcardially perfusedwith phosphate buffer saline (PBS) contain-
ing 5 U/ml heparin. Brains were dissected and embedded into optimal cutting
temperature (OCT) compound (Tissue-Tek, Torrance, CA) on dry ice. OCT-
embedded fresh frozen brain tissue sections were cryosectioned at a thickness
of 14–18 mmand subsequently fixed in ice cold acetone. Sections were blocked
with 5% normal swine serum (Vector Laboratories) for 60 min and incubated in
primary antibody diluted in blocking solution overnight at 4C. Sections were
washed in PBS and incubated with fluorophore-conjugated secondary anti-
bodies. To visualize brain microvessels in specified experiments, sections
were also incubated with biotin- or fluorescein-conjugated L. esculentum lectin
(Vector Laboratories). Sections were subsequently coverslipped with fluores-
cent mounting medium (Dako). For a detailed description of all primary anti-
bodies, secondary antibodies, and lectins used for detection of pericytes
(PDGFRb, NG2, and desmin), endothelial cells (CD31 and lectin), neurons
(SMI-32 and NeuN), microglia (Iba1), astrocytes (AQP4, a-syntrophin, and
GFAP), and other proteins (IgG, fibrin, thrombin, plasmin, and laminin), please
refer to Supplemental Experimental Procedures.
TUNEL
Paraformaldhyde-fixed, paraffin-embedded brain tissue sections were
sectioned at a thickness of 7 mm. Immuofluorescent detection of pericytes422 Neuron 68, 409–427, November 4, 2010 ª2010 Elsevier Inc.(PDGFRb) or neurons (NeuN) and/or endothelial-specific lectin fluorescent
detection was conducted as described above. The DeadEnd Fluorometric
TUNEL system (Promega) was then completed as described by the manufac-
turer. Sections were coverslipped as described above.
Confocal Microscopy Analysis
All coverslipped fluorescently mounted tissue sections were scanned with
a custombuilt Zeiss 510meta confocal laser scanningmicroscopewith a Zeiss
Apochromat 253/0.8 NA or C-Apochromat 403/1.2 NA water immersion
objective (Carl Zeiss Microimaging) For a detailed description of the laser
wavelengths and band pass filters utilized to detect specified fluorophores
please refer to Supplemental Experimental Procedures.
Quantitative image analysis, including desmin-positive pericyte coverage,
NG2-positive pericyte number, lectin-positive capillary length, CD31-positive
capillary length, fluorescent intensity analysis of extravascular IgG and
fibrin accumulation, aquaporin-4-positive or a-syntrophin-positive astrocyte
end-foot coverage, hypoxyprobe-1-positive hypoxic tissue, SMI-32-positive
neuritic density, and counting of GFAP-positive astrocytes, NeuN-positive
neurons, and Iba1-positive microglia was performed by blinded investigators
with the National Institutes of Health ImageJ software. For a detailed descrip-
tion of each analysis please refer to Supplemental Experimental Procedures.
Bright-Field Microscopy Analysis
Imaging and quantification of hematoxylin and eosin stained sections, Prus-
sian blue-positive extravascular hemosiderin deposits, neuronal Golgi-Cox
staining for determination of dendritic length and dendritic spine density and
length, Iba1-positive microglia and neutrophil-specific dichloracetate esterase
staining was conducted with an Olympus AX70 bright-field microscope and
the NIH ImageJ software, respectively. For a detailed description of each
technique and subsequent analysis, where applicable, please refer to Supple-
mental Experimental Procedures.
Multiphoton In Vivo Microscopy Analysis
In vivo multiphoton experiments were performed as we previously described
(Bell et al., 2009; Zhu et al., 2010). Mice were anesthetized intraperitoneally
with 750 mg/kg urethane and 50 mg/kg chloralose. A cranial window was
placed over the parietal cortex. Imaging was completed within 40 min prior
to the presence of any significant inflammation or gliosis. See Supplemental
Experimental Procedures for details. All images were acquired with a custom
built Zeiss 5MP multiphoton microscope (Carl Zeiss Microimaging) coupled to
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(Spectra-Physics, Newport) with a Zeiss 203/1.0 M27 W dipping objective.
The 900 nm multiphoton laser excited fluorescein or TMR and the emission
was collected with a 500–550 nm or 560–615 nm band pass filter, respectively.
Perfused Capillary Length
Fluorescein-conjugated mega-dextran (2,000,000 Da, Invitrogen, 0.1 ml of
10 mg/ml) was injected via the left femoral vein. Multiphoton Z stack images
were immediately taken through the cranial window starting at 50 mm below
the cortical brain surface continuing to scan 500 mm deep through cortical
layers II and III with a 1 mm interval in between each image acquisition. Z stacks
were maximally projected and reconstructed with ZEN software (Carl Zeiss
Microimaging). The perfused capillary length was analyzed with the National
Institutes of Health ImageJ software. For detailed description of the analysis
and rationale of using single time point analysis please refer to Supplemental
Experimental Procedures.
BBB Permeability
Cortical cerebrovascular permeability was determined with rapid in vivo multi-
photon microscopy imaging as we previously described (Zhu et al., 2010).
In brief, TMR-conjugated medium-size dextran (40,000 Da, Invitrogen,
0.1 ml of 10 mg/ml) was injected via the left femoral vein. In vivo time-lapse
images were acquired every 2 min for a total of 30 min. All images were sub-
jected to threshold processing and the extravascular fluorescent intensity
was measured with the integrated density measurement function by a blinded
investigator. The in vivo BBB permeability for TMR-dextran was estimated as
the PS product aswe previously described (Deane et al., 2003; Zhu et al., 2010)
with the following formula: PS = (1-Hct) 1/Iv 3 V x dIt/dt, where Hct is the
hematocrit (45%), Iv is the initial fluorescence intensity of the region of interest
(ROI) within the vessel, It is the intensity of the ROI within the brain at time t, V is
the vessel volume, and assuming 1 g of brain is equivalent to 50 cm2. See
Supplemental Experimental Procedures for details.Noninvasive Fluorometric BBB Permeability Measurements
The BBB permeability to different size tracers including TMR-dextran (MW =
40,000 Da; Invitrogen), Cy3-IgG (MW = 150,000 Da; Invitrogen), FITC-
dextran (MW = 500,000 Da; Sigma), and fluorescein-mega-dextran (MW =
2,000,000 Da; Invitrogen) was assessed in the cortex and hippocampus of
anesthetized mice (100 mg/kg ketamine and 10 mg/kg xylazine, intraperitone-
ally) with a noninvasive fluorometric technique. In brief, these tracers were
injected intravenously via the femoral vein and blood and brain samples
were collected within 30min. Plasma samples and homogenized brain regions
were analyzed with a fluorometric plate reader (Victor) to determine tracer
concentration. The BBB PS product (ml/g/min) was calculated by using the
equation as we described (Mackic et al., 1998): PS = Cb/(0!
TCpxT), where Cb
and 0!
TCp are the fluorescent tracer concentration in brain (per g) and inte-
grated plasma concentration (per ml), respectively, and T is experimental
time. See Supplemental Experimental Procedures for details.Quantitative 14C-iodoantipyrine Autoradiography
Mice were anesthetized with 2%–3% isoflurane in 30% oxygen/70% nitrous
oxide. Local CBF was measured by using intraperitoneal injection of radiola-
beled 14C-iodoantipyrine (IAP) and a single blood sampling from the heart at
the end of the experiment, as we previously described (Zhong et al., 2008).
Blood flow, F (ml/100 g/min), was calculated by using the equation, as we
described (Zhong et al., 2008): F = l/T ln (1- CI(T)/l 0!
T CA(T), where CI(T)
is 14C-IAP radioactivity (disintegrations per minute [dpm])/gram of brain
tissue; T is the experimental time in seconds; CA(T) is 14C-IAP radioactivity
(dpm)/gram plasma determined as 14C-IAP integrated plasma concentration
(0!
T) from 14C tracer lag time after 14C-IAP intraperitoneal injection (zero time)
to the value measured in the blood sample from the frozen heart at the end of
the experiment (at time T), by assuming a linear rise or ramp function over T;
l is 14C-IAP central nervous system tissue to blood partition coefficient,
0.8 ml/g. Arterial blood pressure, pH, and blood gases were monitored
before 14C-IAP administration. There were no significant changes in these
physiological parameters between Pdgfrb+/ or F7 mutants compared
to Pdgfrb+/+ control mice. See for details Supplemental Experimental
Procedures.Laser Doppler Flowmetry
CBF responses to vibrissal stimulation in anesthetized mice (750 mg/kg
urethane and 50 mg/kg chloralose) were determined with laser Doppler flow-
metry, as previously described (Iadecola et al., 1999; Chow et al., 2007; Bell
et al., 2009). The tip of the laser Doppler probe (Transonic Systems) was
stereotaxically placed 0.5 mm above the dura of the cranial window. The right
vibrissae was cut to about 5mmand stimulated by gentle stroking at 3–4Hz for
1 min with a cotton-tip applicator. The percentage increase in CBF due to
vibrissal stimulation was obtained from the baseline CBF and stable maximum
plateau and averaged for the three trials. Arterial blood pressure was
monitored continuously during the experiment. pH and blood gases were
monitored before and after CBF recordings. No significant changes in these
physiological parameters were found between different genotypes and ages.
In a separate set of experiments, CBF responses were determined in the
somatosensory cortex hind limb region following electrical stimulation of the
hind limb with a 2 mA 0.5 s long stimulus.Immunoblotting Analysis
Isolated brain capillaries and capillary-depleted brains were prepared as we
previously described. See Supplemental Experimental Procedures for details.
Immunoblotting studies for the tight junction proteins (ZO-1, occludin, and
claudin-5) and vascular basement membrane proteins (laminin and collagen
IV) in brain capillary homogenates and for blood-derived plasma proteins
(thrombin and plasmin) in capillary-depleted brain homogenates were per-
formed with primary antibodies as described in Supplemental Experimental
Procedures. The relative abundance of studied proteins in microvessels and
capillary-depleted brains was determined with scanning densitometry and
b-actin as a loading control.Behavior
Mice were subjected to novel object location and recognition behavioral tests.
The novel object location and recognition tests were performed as previously
described (Mumby et al., 2002; Winters and Bussey, 2005). For a detailed
description please refer to Supplemental Experimental Procedures.Electrophysiologic Recordings
In vivo, extracellular electrophysiologic recordings were carried out in urethane
anesthetized mice to quantify LFP amplitude, time-to-peak values, and LFP
signals integrated over the time period of activation (SLFP) in layer II of the
hind limb somatosensory cortex following electrical stimulation of the contra-
lateral hind limb. For a detailed description please refer to Supplemental
Experimental Procedures.Neuroinflammation
In addition to quantifying Iba1-positive microglia and neutrophil-specific di-
chloracetate esterase staining, we analyzed relative abundance of several
neuroinflammatory cytokines/chemokines through quantitative real-time
PCR with RNA isolated from snap-frozen brain samples as we previously
described (Zhong et al., 2009). Gene expression was normalized to the house-
keeping gene Gapdh. For cytokine/chemokine primer sequences please
refer to Supplemental Experimental Procedures.Systemic Parameters
We have performed measurements of several hemodynamic, physiological,
and biochemical parameters, including tests for liver and kidney functions.
For a detailed description please refer to Supplemental Experimental
Procedures.Statistical Analysis
Data were analyzed by multifactorial analysis of variance (ANOVA) followed by
Tukey post-hoc tests and Pearson’s correlation analysis. A p value less than
0.05 was considered statistically significant.Neuron 68, 409–427, November 4, 2010 ª2010 Elsevier Inc. 423
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Figure 9. Late Neuroinflammatory Response in Pericyte-Deficient Mice
(A) Confocal microscopy analysis of Iba1-positive microglia in the cerebral cortex of an 8-month-old control Pdgfrb+/+ mouse and 1-, 8-, and 16-month-old
Pdgfrb+/ mice.
(B) The number of Iba1-positive microglia in the cortex of 1, 6- to 8-, and 14- to 16-month-old Pdgfrb+/ mice (black bars) and age-matched Pdgfrb+/+ controls
(white bars). Total of 36 randomly chosen fields (420 3 420 mm) from six nonadjacent cortical sections were analyzed per mouse.
(C) Bright-fieldmicroscopy analysis for neutrophils (red) with dichloracetate esterase staining in the cerebral cortex of an 8-month-oldPdgfrb+/+ mouse and 1-, 8-,
and 16-month-old Pdgfrb+/ mice. MCAO, a positive control showing neutrophils infiltration (arrows) of ischemic brain tissue of a Pdgfrb+/+mouse 24 hr after
permanent middle cerebral artery occlusion (MCAO).
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Figure 10. Vascular-Mediated Neurodegen-
eration Following Pericyte Loss
PDGFRb-deficient signaling in brain pericytes
leads to a progressive age-dependent pericyte
loss resulting in (1) reductions in brain microcircu-
lation with diminished CBF and CBF responses
to a stimulus (CBF dysregulation), leading to a
chronic perfusion stress and hypoxia, and (2)
BBB breakdown with accumulation of serum
proteins and several cytotoxic and neurotoxic
pathologic deposits in brain. Both arms 1 and 2
may contribute to secondary neuronal injury and
neurodegeneration mediated by a neurovascular
insult.
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